Elevated preoperative neutrophil-lymphocyte ratio is associated with poor prognosis in hepatocellular carcinoma patients treated with liver transplantation: A meta-analysis

Gastroenterology Research and Practice

Volumn 2016, Issue , 2016, Pages

  Sun, Xiao Dong ^a   Shi, Xiao Ju ^a   Chen, Yu Guo ^a   Wang, Chuan Lei ^a   Ma, Qiang ^a   Lv, Guo Yue ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; DISEASE FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; META ANALYSIS; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; REVIEW; SURVIVAL RATE; TUMOR RECURRENCE;

EID: 84956909403     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2016/4743808     Document Type: Review

References (32)

1. J. S Au and C. T Frenette, "Management of hepatocellular carcinoma: current status and future directions, " Gut and Liver, vol. 9, no. 4, pp. 437-448, 2015.
2. R. L. Siegel, K. D. Miller, and A. Jemal, "Cancer statistics, 2015, " CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5-29, 2015.
3. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, "Global cancer statistics, 2012, " CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87-108, 2015.
4. Z. V. Fong and K. K. Tanabe, "The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review, " Cancer, vol. 120, no. 18, pp. 2824-2838, 2014.
5. S. F. Altekruse, K. A. Mcglynn, L. A. Dickie, and D. E. Kleiner, "Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008, " Hepatology, vol. 55, no. 2, pp. 476-482, 2012.
6. B. Macdonald, J. L. Sewell, A. M. Harper, J. P. Roberts, and F. Y. Yao, "Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients inOPTN Region 5, " Clinical Transplantation, vol. 29, no. 6, pp. 506-512, 2015.
7. D. C. McMillan, "Systemic inflammation, nutritional status and survival in patients with cancer, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 3, pp. 223-226, 2009.
8. X. Yang, Y. Huang, J. F. Feng, and J. S. Liu, "Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis, " Onco Targets Therapy, vol. 8, pp. 789-794, 2015.
9. X. Zhang, W. Zhang, and L.-J. Feng, "Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis, " PLoS ONE, vol. 9, no. 11, Article ID e111906, 2014.
10. M.-X. Li, X.-M. Liu, X.-F. Zhang, et al., "Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis, " International Journal of Cancer, vol. 134, no. 10, pp. 2403-2413, 2014.
11. J. J. Yang, Z. G. Hu, W. X. Shi, et al., "Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a metaanalysis, " World Journal of Gastroenterology, vol. 21, no. 9, pp. 2807-2815, 2015.
12. Y. Wei, Y.-Z. Jiang, and W.-H. Qian, "Prognostic role of NLR in urinary cancers: a meta-analysis, " PLoS ONE, vol. 9, no. 3, Article ID e92079, 2014.
13. B. Peng, Y. H. Wang, Y. M. Liu, and L. X. Ma, "Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and metaanalysis, " International Journal of Clinical and Experimental Medicine, vol. 8, no. 3, pp. 3098-3106, 2015.
14. M. K. B. Parmar, V. Torri, and L. Stewart, "Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, " Statistics in Medicine, vol. 17, no. 24, pp. 2815-2834, 1998.
15. A. Stang, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies inmetaanalyses, " European Journal of Epidemiology, vol. 25, no. 9, pp. 603-605, 2010.
16. J. P. T. Higgins and S. G. Thompson, "Quantifying heterogeneity in ameta-analysis, " Statistics inMedicine, vol. 21, no. 11, pp. 1539-1558, 2002.
17. G. H. Na, D. G. Kim, J. H. Han, et al., "Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation, "World Journal ofGastroenterology, vol. 20, no. 21, pp. 6594-6601, 2014.
18. J. Shindoh, Y. Sugawara, R. Nagata, et al., "Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma, " Transplant International, vol. 27, no. 4, pp. 391-398, 2014.
19. G.-Q. Xiao, C. Liu, D.-L. Liu, J.-Y. Yang, and L.-N. Yan, "Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation, " World Journal of Gastroenterology, vol. 19, no. 45, pp. 8398-8407, 2013.
20. A. R. Limaye, V. Clark, C. Soldevila-Pico, et al., "Neutrophillymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma, " Hepatology Research, vol. 43, no. 7, pp. 757-764, 2013.
21. T. Motomura, K. Shirabe, Y. Mano, et al., "Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment, " Journal of Hepatology, vol. 58, no. 1, pp. 58-64, 2013.
22. N. Harimoto, K. Shirabe, H. Nakagawara, et al., "Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio, " Transplantation, vol. 96, no. 11, pp. 1008-1012, 2013.
23. T. Yoshizumi, T. Ikegami, S. Yoshiya, et al., "Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma, " Hepatology Research, vol. 43, no. 7, pp. 709-716, 2013.
24. G.-Y. Wang, Y. Yang, H. Li, et al., "A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBVassociated hepatocellular carcinoma after liver transplantation, " PLoS ONE, vol. 6, no. 9, Article ID e25295, 2011.
25. V. R. Bertuzzo, M. Cescon, M. Ravaioli, et al., "Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers, " Transplantation, vol. 91, no. 11, pp. 1279-1285, 2011.
26. K. J. Halazun, M. A. Hardy, A. A. Rana, et al., "Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma, " Annals of Surgery, vol. 250, no. 1, pp. 141-151, 2009.
27. F. Balkwill and A. Mantovani, "Inflammation and cancer: back to Virchow?" The Lancet, vol. 357, no. 9255, pp. 539-545, 2001.
28. S. P. Hussain and C. C. Harris, "Inflammation and cancer: an ancient link with novel potentials, " International Journal of Cancer, vol. 121, no. 11, pp. 2373-2380, 2007.
29. S. Rasch and H. Algül, "A clinical perspective on the role of chronic inflammation in gastrointestinal cancer, " Journal of Clinical and Experimental Gastroenterology, vol. 7, pp. 261-272, 2014.
30. E. Elinav, R. Nowarski, C. A. Thaiss, B. Hu, C. Jin, and R. A. Flavell, "Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms, " Nature Reviews Cancer, vol. 13, no. 11, pp. 759-771, 2013.
31. D. C. McMillan, T. Preston, W. S. Watson, et al., "Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer, " The British Journal of Surgery, vol. 81, no. 7, pp. 1011-1014, 1994.
32. W.-K. Xiao, D. Chen, S.-Q. Li, S.-J. Fu, B.-G. Peng, and L.-J. Liang, "Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: ameta-analysis, "BMC Cancer, vol. 14, article 117, 2014.